Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-045063
Filing Date
2025-10-15
Accepted
2025-10-15 12:24:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4008
  Complete submission text file 0001628280-25-045063.txt   5464
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Subject) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38599 | Film No.: 251394118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Boyd Peter E. (Reporting) CIK: 0001739816 (see all company filings)

Type: 144